Informatie:
Fout:
ID
45822
Beschrijving
Principal Investigator: MeSH: Neoplasms,Sarcoma,Sarcoma, Ewing,Rhabdomyosarcoma,Wilms Tumor,Desmoplastic Small Round Cell Tumor,Carcinoma, Transitional Cell,Rhabdoid Tumor,Sarcoma, Synovial,Neuroblastoma,Neuroendocrine tumors https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001052 The Center for Cancer Research (CCR), of the intramural NCI undertook a multidimensional clinical genomics study of children and adolescent young adults with relapsed and refractory cancers who were enrolled on other therapeutic trials to determine the feasibility of a genome guided precision therapy protocol in these patients.
Link
Trefwoorden
Versies (1)
- 09-07-23 09-07-23 - Simon Heim
Houder van rechten
dbGAP
Geüploaded op
9 juli 2023
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs001052 Multi-Dimensional ClinOmics for Precision Therapy
Sample ID, body site where sample was collected, analyte type, tumor status, primary metastatic tumor, name of the center which conducted sequencing of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- Subject ID, sample ID, and sample use variable obtained from participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- Subject ID, age onset, and sex of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary metastatic tumor, name of the center which conducted sequencing of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
Similar models
Sample ID, body site where sample was collected, analyte type, tumor status, primary metastatic tumor, name of the center which conducted sequencing of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- Subject ID, sample ID, and sample use variable obtained from participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- Subject ID, age onset, and sex of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary metastatic tumor, name of the center which conducted sequencing of participants with relapsed and refractory cancer and involved in the "Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research" project.
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
SAMPLE_ID
Item
De-identified sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYT_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
CL Item
Is not a tumor (N)
C0027651 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,2])
CL Item
Is tumor (Y)
C0027651 (UMLS CUI [1,1])
PRIMARY_METASTATIC_TUMOR
Item
Primary metastatic tumor
text
C2939420 (UMLS CUI [1,1])
SEQUENCING_CENTER
Item
Name of the center which conducted sequencing
string
C1301943 (UMLS CUI [1,1])
C5575037 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
C5575037 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])